The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of 2019-nCoV Infections

doi 10.20944/preprints202002.0147.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Potential Benefits of Precise Corticosteroids Therapy for Severe 2019-nCoV Pneumonia

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

The First Two Cases of 2019‐nCoV in Italy: Where They Come From?

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Genomic Variance of the 2019‐nCoV Coronavirus

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections From Wuhan, China: Key Points for the Radiologist

Radiology
Nuclear MedicineRadiologyImaging
2020English

Wuhan 2019 Novel Coronavirus - 2019-nCoV

Materials and Methods
2020English

Emerging Understandings of 2019-nCoV

The Lancet
Medicine
2020English

Therapeutic Options for the 2019 Novel Coronavirus (2019-nCoV)

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2020English

Novel Coronavirus (2019-nCoV) Cases in Hong Kong and Implications for Further Spread

Journal of Infection
Infectious DiseasesMicrobiology
2020English

Broadly Neutralizing Antibodies for Therapy of Viral Infections

Antibody Technology Journal
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy